A team of scientists is investigating a new type of antibody, which stimulates the immune system to target cancer cells and slows tumour growth in treatment-resistant breast and ovarian cancers. ...
Celltrion, a major South Korean biopharmaceutical firm, on Thursday said it has launched its biosimilar product for Stelara, an autoimmune disease treatment, in the United States. ...
Scientists are sounding the alarm about a concerning genetic mutation of the H5N1 bird flu virus, recently identified in four dairy cow herds, as this mutation could increase the risk of mammal-to-mammal transmission and disease severity. ...
The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic versions in the market. ...
In a first, an Australian man has become the first in the world to live with a durable total artificial heart implant -- made of titanium ...
Nearly one out of 10 older adults in South Korea suffer from Alzheimer's disease, with the number of dementia patients expected...
The government is committed to improving care and treatment accessibility for patients with cancer and has been undertaking ...
Under the ambitious ‘75 by 25’ initiative, India has treated 42.01 million people for hypertension or high blood pressure and 25.27...
Indian women have established their unlimited capabilities, and potential globally, said Annapurna Devi, Union Minister, Women and Child Development (WCD), at the UN Headquarters in New York. ...
Amid the looming threat of zoonotic spillovers, Union Minister Dr. Jitendra Singh on Monday said that India will strengthen its re...